Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

BASF reports on novel thrombin inhibitors

Oct. 18, 1996

Bristol-Myers Squibb to develop Toray antiplatelet agent in the U.S. and Canada

Oct. 11, 1996

Fujisawa's antiplatelet agent in clinical trials

Oct. 11, 1996

Integrin receptor antagonists described by SKB

Oct. 11, 1996

Antiplatelet fibrinogen antagonists from Yamanouchi

Oct. 11, 1996

Fibrinogen antagonist research continues at Merck & Co.

Oct. 11, 1996

BB-10153 development progresses

Oct. 4, 1996

Fibrinogen antagonists reported by Searle

Oct. 4, 1996

Boehringer Mannheim reports fibrinogen antagonists for thromboembolic conditions

Oct. 4, 1996

Joint venture formed for development of oral heparin

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...